1,936
Views
40
CrossRef citations to date
0
Altmetric
Letters to the Editor

Flare-up: An often unreported phenomenon nevertheless familiar to oncologists prescribing tyrosine kinase inhibitors

, , &
Pages 621-624 | Received 22 Sep 2008, Published online: 08 Jul 2009

Figures & data

Figure 1.  Chest CT scan of the thorax 1 month prior to sunitinib discontinuation after 16 cycles of treatment (20-12-2007).

Figure 1.  Chest CT scan of the thorax 1 month prior to sunitinib discontinuation after 16 cycles of treatment (20-12-2007).

Figure 2.  Tumor progression (“flare-up”) documented by chest radiograph (a) and chest CT scan (b) at admission (6 days after discontinuation of sunitinib for surgical intervention) (23-01-2008).

Figure 2.  Tumor progression (“flare-up”) documented by chest radiograph (a) and chest CT scan (b) at admission (6 days after discontinuation of sunitinib for surgical intervention) (23-01-2008).

Figure 3.  Tumor regression documented by chest radiograph 1 month (a, 04-03-3008) and confirmed by CT scan 10 weeks after resuming sunitinib (b) 03-04-2008).

Figure 3.  Tumor regression documented by chest radiograph 1 month (a, 04-03-3008) and confirmed by CT scan 10 weeks after resuming sunitinib (b) 03-04-2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.